Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans (Q43515119)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans |
scientific article |
Statements
1 reference
Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans (English)
1 reference
Amass L
1 reference
Kamien JB
1 reference
Mikulich SK
1 reference
1 January 2001
1 reference
1 reference
Identifiers
1 reference